AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,188 | +157.3% | 339,846 | +137.5% | 0.01% | +175.0% |
| Q2 2023 | $6,680 | +126.1% | 143,078 | +85.3% | 0.00% | +300.0% |
| Q1 2023 | $2,954 | -47.9% | 77,224 | -25.4% | 0.00% | -66.7% |
| Q4 2022 | $5,674 | -85.8% | 103,552 | +8616.5% | 0.00% | – |
| Q3 2022 | $40,000 | -64.9% | 1,188 | -90.2% | 0.00% | – |
| Q2 2022 | $114,000 | +6.5% | 12,078 | +58.7% | 0.00% | – |
| Q1 2022 | $107,000 | -92.9% | 7,610 | -89.3% | 0.00% | – |
| Q4 2021 | $1,498,000 | +375.6% | 70,860 | +403.7% | 0.00% | – |
| Q3 2021 | $315,000 | +131.6% | 14,068 | +156.9% | 0.00% | – |
| Q2 2021 | $136,000 | -63.1% | 5,476 | -57.1% | 0.00% | – |
| Q1 2021 | $369,000 | +141.2% | 12,757 | +114.8% | 0.00% | – |
| Q4 2020 | $153,000 | -39.3% | 5,938 | -27.3% | 0.00% | – |
| Q3 2020 | $252,000 | -41.9% | 8,169 | -53.0% | 0.00% | – |
| Q2 2020 | $434,000 | +635.6% | 17,399 | +525.4% | 0.00% | – |
| Q1 2020 | $59,000 | -47.3% | 2,782 | -44.6% | 0.00% | – |
| Q4 2019 | $112,000 | +83.6% | 5,018 | +88.9% | 0.00% | – |
| Q3 2019 | $61,000 | – | 2,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |